CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Crystal Adam acquired 81,250 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 89,545 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,842 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award General Counsel acquired 23,898 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 31,697 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 237,000 shares at an average $4.41 ($1,044,573)
- 4 Open-market buy 10% owner bought 182,000 shares at an average $3.92 ($714,096)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 8 · 156 filings